RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Autoimmunity profile in interferon beta- 1a treated Multiple Sclerosis patients. the auprin study: comparison of 2 different dosage of subcutaneous interferon-beta 1a
2005-01-01 E. VERDUN; L. GIORDANO; M.A. CUCCI; A. RICCI; P. BARBERO; A. PIPIERI; M. CLERICO; G. AIMO; L. DURELLI; THE AUPRIN STUDY GROUP
Autoimmunity profile in interferon beta- 1a treated multiple sclerosis patients. the auprin study: comparision of 2 different dosage of subcutaneous interferon-beta 1a.
2004-01-01 E. VERDUN; A. RICCI; M.A. CUCCI; P. BARBERO; A. PIPIERI; M. CLERICO; L. GIORDANO; L. DELFICO; T. TASSINARI; L. MOTTI; M. PACIELLO; A. REGGIO; G. AIMO; L. DURELLI; ON BEHALF OF THE AUPRIN STUDY GROUP
Autoimmunity profile in interferon beta-1a treated Multiple Sclerosis patients. The AUPRIN Study: comparison of 2 different dosages of subcutaneous interferon beta-1a
2004-01-01 E. VERDUN; A. RICCI; M.A. CUCCI; P. BARBERO; A. PIPIERI; M. CLERICO; L. GIORDANO; L. DELFICO; G. AIMO; T. M. PACIELLO; T. TASSINARI; L. MOTTI; A. REGGIO; L. DURELLI; THE AUPRIN STUDY GROUP
Autonomic function in different patterns of chronic inflammatory demyelinating polyneuropathy.
2002-01-01 D. COCITO; G. ISOARDO; P. CIARAMITARO; S. MAULE; R. QUADRI; B. BERGAMASCO; L. DURELLI
Best indicator of persisting disease activity
2005-01-01 L. DURELLI; E. VERDUN; P. BARBERO; M. CLERICO; B. FERRERO; E. VERSINO; G. GIULIANI; E. MONTANARI; AND THE OPTIMS STUDY GROUP
Best–pgx: design of a pharmacogenomic and pharmacogenetic study to identify criteria for prediction of treatment response to interferon beta -1b.
2004-01-01 L. KAPPOS; L. ACHTNICHTS; L. DURELLI; O. FERNANDEZ; H. PETEREIT; J. DE S; A. SIVA; E.W. RADU; M. DAUMER FOR THE BEST PGX STUDY GROUP
BLOOD HYPERTENSION DURING MITOXANTRONE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT
2003-01-01 P. BARBERO; E. VERDUN; M. CLERICO; A. PIPIERI; L. DURELLI
Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study
2015-01-01 Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L
Brain volume changes in patients at presentation with suspected Multiple Sclerosis: results from the Etoms Study
2002-01-01 G. COMI; M. INGLESE; N. DE STEFANO; S. SMITH; F. BARKHOF; L. DURELLI; G. EDAN; O. FERNANDEZ; H.P. HARTUNG; P.M. MATTHEWS; P. SEELDRAYERS; P.S. SORENSEN; V. MARTINELLI; O.R. HOMMES; M. FILIPPI
can the increase of T-helper 17 Lymphocyte percentage in peripheral blood anticipate a relapse in relapsing remitting multiple sclerosis?
2010-01-01 Luca Durelli; Marinella Clerico; Simona Rolla; Giulia Contessa; Stefania De Mercanti; Antoni Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Roberto Cavallo; Luisa Sosso; Francesco Novelli
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Autoimmunity profile in interferon beta- 1a treated Multiple Sclerosis patients. the auprin study: comparison of 2 different dosage of subcutaneous interferon-beta 1a | 2005 | E. VERDUN; L. GIORDANO; M.A. CUCCI; A. RICCI; P. BARBERO; A. PIPIERI; M. CLERICO; G. AIMO; L. DURELLI; THE AUPRIN STUDY GROUP | |
| Autoimmunity profile in interferon beta- 1a treated multiple sclerosis patients. the auprin study: comparision of 2 different dosage of subcutaneous interferon-beta 1a. | 2004 | E. VERDUN; A. RICCI; M.A. CUCCI; P. BARBERO; A. PIPIERI; M. CLERICO; L. GIORDANO; L. DELFICO; T. TASSINARI; L. MOTTI; M. PACIELLO; A. REGGIO; G. AIMO; L. DURELLI; ON BEHALF OF THE AUPRIN STUDY GROUP | |
| Autoimmunity profile in interferon beta-1a treated Multiple Sclerosis patients. The AUPRIN Study: comparison of 2 different dosages of subcutaneous interferon beta-1a | 2004 | E. VERDUN; A. RICCI; M.A. CUCCI; P. BARBERO; A. PIPIERI; M. CLERICO; L. GIORDANO; L. DELFICO; G. AIMO; T. M. PACIELLO; T. TASSINARI; L. MOTTI; A. REGGIO; L. DURELLI; THE AUPRIN STUDY GROUP | |
| Autonomic function in different patterns of chronic inflammatory demyelinating polyneuropathy. | 2002 | D. COCITO; G. ISOARDO; P. CIARAMITARO; S. MAULE; R. QUADRI; B. BERGAMASCO; L. DURELLI | |
| Best indicator of persisting disease activity | 2005 | L. DURELLI; E. VERDUN; P. BARBERO; M. CLERICO; B. FERRERO; E. VERSINO; G. GIULIANI; E. MONTANARI; AND THE OPTIMS STUDY GROUP | |
| Best–pgx: design of a pharmacogenomic and pharmacogenetic study to identify criteria for prediction of treatment response to interferon beta -1b. | 2004 | L. KAPPOS; L. ACHTNICHTS; L. DURELLI; O. FERNANDEZ; H. PETEREIT; J. DE S; A. SIVA; E.W. RADU; M. DAUMER FOR THE BEST PGX STUDY GROUP | |
| BLOOD HYPERTENSION DURING MITOXANTRONE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT | 2003 | P. BARBERO; E. VERDUN; M. CLERICO; A. PIPIERI; L. DURELLI | |
| Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study | 2015 | Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L | |
| Brain volume changes in patients at presentation with suspected Multiple Sclerosis: results from the Etoms Study | 2002 | G. COMI; M. INGLESE; N. DE STEFANO; S. SMITH; F. BARKHOF; L. DURELLI; G. EDAN; O. FERNANDEZ; H.P. HARTUNG; P.M. MATTHEWS; P. SEELDRAYERS; P.S. SORENSEN; V. MARTINELLI; O.R. HOMMES; M. FILIPPI | |
| can the increase of T-helper 17 Lymphocyte percentage in peripheral blood anticipate a relapse in relapsing remitting multiple sclerosis? | 2010 | Luca Durelli; Marinella Clerico; Simona Rolla; Giulia Contessa; Stefania De Mercanti; Antoni Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Roberto Cavallo; Luisa Sosso; Francesco Novelli |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 137
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 137
Data di pubblicazione
- 2010 - 2017 20
- 2002 - 2009 117
Editore
- Springer-Verlag 53
- Lippincot Williams and Wilkins 14
- SAGE publications 9
- SAGE Publications 8
- SAGE Pubblications 6
- Antonio Federico 5
- Lippincott Williams and Wilkins 4
- Robert A. Gross 4
- Springer 4
- Springer Verlag-Italia 4
Rivista
- JOURNAL OF NEUROLOGY 1
Keyword
- Active learning 1
- Cooperative learning 1
- Flipped classroom 1
- Global education 1
- Global university 1
- INTERFERONI 1
- SCLEROSI MULTIPLA 1
- Student centered teaching methods 1
- TH17 1
- TH22 1
Lingua
- eng 137
Accesso al fulltext
- no fulltext 135
- open 2